Related Experiment Video
Updated: Jan 15, 2026

09:53
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
7.9K
The Hidden Regulators: MicroRNAs in Pediatric Heart Development and Disease
Adam Kozik1, Michał Piotrowski1, Julia Izabela Karpierz1,2
1CAROL-Cardiothoracic Anatomy Research Operative Lab, Department of Cardiovascular Surgery and Transplantology, Institute of Cardiology, Jagiellonian University Medical College, 31-008 Krakow, Poland.
Journal of Clinical Medicine
|October 16, 2025
Summary
MicroRNAs (miRNAs) are key regulators of heart development and function. This review explores their role in pediatric heart conditions, highlighting their potential as diagnostic biomarkers and therapeutic targets.
Area of Science:
- Cardiovascular Biology
- Molecular Genetics
- Pediatric Cardiology
Background:
- MicroRNAs (miRNAs) are crucial non-coding RNA molecules regulating gene expression post-transcriptionally.
- They play a significant role in the intricate regulatory networks governing cardiac development and function.
- Dysregulation of miRNAs is implicated in various cardiovascular pathologies.
Purpose of the Study:
- To review the biogenesis and function of miRNAs in normal heart development.
- To elucidate the impact of miRNAs on the pathogenesis of congenital and acquired pediatric heart diseases.
- To explore the clinical utility of miRNAs as biomarkers and therapeutic agents in pediatric cardiology.
Main Methods:
- This narrative review synthesizes existing literature on miRNA research in pediatric cardiology.
- Key findings from studies on miRNA biogenesis, function, and disease association are discussed.
- Emphasis is placed on clinical implications and future research directions.
Main Results:
- Specific miRNAs are vital for normal cardiac morphogenesis and function.
- Altered miRNA expression patterns are associated with congenital heart defects (e.g., HLHS, TOF, BAV) and acquired conditions.
- Circulating and tissue miRNAs show promise as non-invasive biomarkers for diagnosis and monitoring.
Conclusions:
- MicroRNAs are critical regulators in pediatric heart development and disease.
- miRNA signatures offer potential for early diagnosis and personalized treatment strategies.
- Further research is essential to overcome challenges and translate miRNA-based therapies into clinical practice for pediatric cardiology.
Related Concept Videos
MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K

